GC Aesthetics® at the ABS Conference 2026: Advancing Innovation in Breast Surgery
GC Aesthetics® is proud to participate in the Association of Breast Surgery (ABS) Conference 2026, taking place on June 8–9 at the SEC Glasgow, United Kingdom.
As one of the UK's leading scientific meetings dedicated to breast surgery, the ABS Conference brings together surgeons, healthcare professionals, researchers, and industry partners to exchange knowledge, discuss emerging evidence, and explore innovations that contribute to improving patient outcomes.
Connecting with the Breast Surgery Community
The ABS Conference provides an important platform for collaboration and education within the breast surgery field. GC Aesthetics® is delighted to attend alongside its UK & Ireland team, engaging with healthcare professionals and showcasing solutions designed to support both aesthetic and reconstructive breast procedures.
Through ongoing investment in clinical evidence, innovation, and education, GC Aesthetics® remains committed to supporting surgeons with solutions that address the evolving needs of patients throughout their breast care journey.
Sponsored Mini Symposium: PERLE™ Clinical Outcomes at Five Years
A key highlight of this year's congress will be the GC Aesthetics® sponsored mini symposium:
Low Rates of Capsular Contracture and Reoperation at Five Years with the PERLE™ Implant
Presented by Mr. James Lucocq (United Kingdom)
Date: Monday, June 8
Time: 15:40
Location: Exhibition Auditorium 2
During this session, attendees will have the opportunity to learn more about the clinical outcomes associated with PERLE™, GC Aesthetics®' smooth, opaque, 100% filled breast implant. The presentation will focus on five-year data relating to capsular contracture and reoperation rates, contributing to the growing body of evidence supporting implant performance and patient outcomes.
Supporting Innovation Through Evidence and Education
At GC Aesthetics®, innovation goes beyond product development. Through educational initiatives, scientific partnerships, and ongoing clinical research, the company continues to support surgeons worldwide with evidence-based solutions and resources.
The ABS Conference represents another opportunity to engage with the breast surgery community, share clinical insights, and contribute to discussions that help shape the future of breast aesthetics and reconstruction.
We look forward to welcoming delegates in Glasgow and continuing our mission of delivering innovation, education, and support across the breast surgery pathway.